Patents by Inventor Donna L. Moyer

Donna L. Moyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Non-toxic non-toxigenic non-pathogenic fusarium expression system
    Patent number: 7163804
    Abstract: The present invention relates non-toxic, non-toxigenic, non-pathogenic recombinant Fusarium host cells of the section Discolor or a teleomorph or synonym thereof, comprising a nucleic acid sequence encoding a heterologous protein operably linked to a promoter.
    Type: Grant
    Filed: December 15, 1999
    Date of Patent: January 16, 2007
    Assignee: Novozymes, Inc.
    Inventors: John C. Royer, Donna L. Moyer, Jeffrey R. Shuster, Yoder T. Wendy
  • Non-toxic, non-toxigenic, non-pathogenic Fusarium expression system
    Patent number: 6060305
    Abstract: The present invention relates non-toxic, non-toxigenic, non-pathogenic recombinant Fusarium host cells of the section Discolor or a teleomorph or synonym thereof, comprising a nucleic acid sequence encoding a heterologous protein operably linked to a promoter.
    Type: Grant
    Filed: March 13, 1997
    Date of Patent: May 9, 2000
    Assignee: Novo Nordisk Biotech, Inc.
    Inventors: John C. Royer, Donna L. Moyer, Yoder T. Wendy, Jeffrey R. Shuster
  • Metalloprotease having increased activity
    Patent number: 5843753
    Abstract: The present invention relates to a novel metalloprotease obtainable from a fungus having increased proteolytic activity. Additionally, the invention related to isolated nucleic acid fragments encoding said metalloprotease as well as vectors, DNA constructs, and recombinant host cells comprising said nucleic acid fragments.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: December 1, 1998
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang, Sven Branner
  • Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
    Patent number: 5837847
    Abstract: The invention is related to a non-toxic, non-toxigenic, non-pathogenic recombinant Fusarium, e.g., Fusarium graminearum host cell comprising a nucleic acid sequence encoding a heterologous protein operably linked to a promoter. The invention further relates to a method for the production of recombinant proteins using such Fusarium host cells. The invention also relates to a promoter and terminator sequence which may be used in such cells.
    Type: Grant
    Filed: August 29, 1997
    Date of Patent: November 17, 1998
    Assignee: Novo Nordisk Biotech, Inc.
    Inventors: John C. Royer, Donna L. Moyer, Yoder T. Wendy, Jeffrey R. Shuster
  • Metalloprotease having increased activity
    Patent number: 5807729
    Abstract: The present invention relates to a novel metalloprotease obtainable from a fungus having increased proteolytic activity. Additionally, the invention related to isolated nucleic acid fragments encoding said metalloprotease as well as vectors, DNA constructs, and recombinant host cells comprising said nucleic acid fragments.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: September 15, 1998
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang, Sven Branner
  • Processes for producing an enzyme
    Patent number: 5702934
    Abstract: The present invention is related to a process for producing an active enzyme comprising fermenting the proform of the active enzyme in the present of a proteolytic enzyme different from the active enzyme and capable of converting the proenzyme into an active enzyme as well as to host cells, recombinant expression vectors and host cells suitable for use in the process.
    Type: Grant
    Filed: May 4, 1994
    Date of Patent: December 30, 1997
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Sven Hastrup, Sven Branner, Birthe Ravn J.o slashed.rgensen, Tove Christensen, Birgitte Bojer J.o slashed.rgensen, Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang
  • Metalloprotease having increased activity
    Patent number: 5691162
    Abstract: The present invention relates to a novel metalloprotease obtainable from a fungus having increased proteolytic activity. Additionally, the invention related to isolated nucleic acid fragments encoding said metalloprotease as well as vectors, DNA constructs, and recombinant host cells comprising said nucleic acid fragments.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: November 25, 1997
    Assignees: Novo Nordisk A/S, Novo Nordisk Biotech, Inc.
    Inventors: Jeffrey R. Shuster, Mark Madden, Donna L. Moyer, Claus Fuglsang, Sven Branner